A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Status:
Completed
Trial end date:
2020-12-04
Target enrollment:
Participant gender:
Summary
This is a 2-part, study to determine the safety, tolerability and pharmacokinetics of oral
dabrafenib in children and adolescent subjects with advanced BRAF V600 mutation-positive
solid tumors.